Market Overview

Benzinga's Top Downgrades

Share:
Related BMRN
Is BioMarin Still An Outperform At This Research Firm?
BioMarin Completes Rolling NDA Submission to FDA for Drisapersen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping
Insider Wisdom And The New Medicine (Seeking Alpha)
Related PEG
Public Service Enterprise Q1 Profit Tops Expectations
Earnings Scheduled For May 1, 2015

Analysts at Deutsche Bank downgraded BioMarin Pharmaceutical (NASDAQ: BMRN) from “buy” to “hold.” BioMarin's shares closed at $38.70 on Friday. BioMarin's trailing-twelve-month ROE is -11.59%.

Analysts at FBR Capital downgraded Public Service Enterprise Group (NYSE: PEG) from “market perform” to “underperform.” PSEG's stock closed at $32.13 on Friday. PSEG's PEG ratio is 6.66.

Analysts at KeyBanc Capital downgraded Ignite Restaurant Group (NASDAQ: IRG) from “buy” to “hold.” Ignite Restaurant's shares closed at $15.12 on Friday. Ignite Restaurant's trailing-twelve-month profit margin is 2.99%.

UBS downgraded Westlake Chemical (NYSE: WLK) from “neutral” to “sell.” Westlake Chemical's shares closed at $69.50 on Friday. Westlake Chemical's trailing-twelve-month ROA is 9.24%.

Latest Ratings for BMRN

DateFirmActionFromTo
May 2015JP MorganMaintainsOverweight
Mar 2015JefferiesMaintainsBuy
Feb 2015CitigroupMaintainsBuy

View More Analyst Ratings for BMRN
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BMRN + IRG)

Around the Web, We're Loving...

Get Benzinga's Newsletters